RATIONALE: The stop-signal reaction time (SSRT) task measures inhibition of a response that has already been initiated, i.e. the ability to stop. 'Impulsive' human subjects, e.g. with attention deficit and hyperactivity disorder (ADHD), have longer SSRTs. Both SSRT and go-trial reaction time (GoRT) may be sensitive to drugs such as d-amphetamine, methylphenidate and modafinil, both in normal subjects and those with ADHD. OBJECTIVES: To investigate the effects of modafinil (3, 10, 30 and 100 mg/kg) and methylphenidate (0.3, 1.0 and 3.0 mg/kg) on SSRT task performance in the rat. To investigate the possible contribution of dopamine receptors in the action of these drugs using the mixed D1/D2 dopamine receptor antagonist cis-flupenthixol. RESULTS: Modafinil significantly decreased SSRT with little effect on GoRT but only in rats with slow baseline SSRTs. Fast SSRTs were not changed by modafinil. Methylphenidate decreased GoRTs of all rats. However, methylphenidate had baseline-dependent effects on SSRT, decreasing SSRT in slow responders but increasing SSRT in fast responders. Cis-flupenthixol (0.01, 0.04 and 0.125 mg/kg) had no effects on SSRT but increased GoRT at higher doses. At the lowest dose (0.01 mg/kg), cis-flupenthixol failed to disrupt the SSRT-decreasing effects of either modafinil or methylphenidate, whereas at 0.04 mg/kg, the cis-flupenthixol-dependent increase in GoRT was antagonised by methylphenidate but not by modafinil. CONCLUSIONS: This evidence supports a hypothesis that stop and go processes are under control of distinct neurochemical mechanisms.
RATIONALE: The stop-signal reaction time (SSRT) task measures inhibition of a response that has already been initiated, i.e. the ability to stop. 'Impulsive' human subjects, e.g. with attention deficit and hyperactivity disorder (ADHD), have longer SSRTs. Both SSRT and go-trial reaction time (GoRT) may be sensitive to drugs such as d-amphetamine, methylphenidate and modafinil, both in normal subjects and those with ADHD. OBJECTIVES: To investigate the effects of modafinil (3, 10, 30 and 100 mg/kg) and methylphenidate (0.3, 1.0 and 3.0 mg/kg) on SSRT task performance in the rat. To investigate the possible contribution of dopamine receptors in the action of these drugs using the mixed D1/D2 dopamine receptor antagonist cis-flupenthixol. RESULTS: Modafinil significantly decreased SSRT with little effect on GoRT but only in rats with slow baseline SSRTs. Fast SSRTs were not changed by modafinil. Methylphenidate decreased GoRTs of all rats. However, methylphenidate had baseline-dependent effects on SSRT, decreasing SSRT in slow responders but increasing SSRT in fast responders. Cis-flupenthixol (0.01, 0.04 and 0.125 mg/kg) had no effects on SSRT but increased GoRT at higher doses. At the lowest dose (0.01 mg/kg), cis-flupenthixol failed to disrupt the SSRT-decreasing effects of either modafinil or methylphenidate, whereas at 0.04 mg/kg, the cis-flupenthixol-dependent increase in GoRT was antagonised by methylphenidate but not by modafinil. CONCLUSIONS: This evidence supports a hypothesis that stop and go processes are under control of distinct neurochemical mechanisms.
Authors: A Marije Boonstra; J J Sandra Kooij; Jaap Oosterlaan; Joseph A Sergeant; Jan K Buitelaar Journal: J Clin Exp Neuropsychol Date: 2005-04 Impact factor: 2.475
Authors: Danielle C Turner; Trevor W Robbins; Luke Clark; Adam R Aron; Jonathan Dowson; Barbara J Sahakian Journal: Psychopharmacology (Berl) Date: 2002-11-01 Impact factor: 4.530
Authors: Marijn Lijffijt; J Leon Kenemans; Annemiek ter Wal; Elise H Quik; C Kemner; Herman Westenberg; Marinus N Verbaten; Herman van Engeland Journal: Eur Psychiatry Date: 2005-07-01 Impact factor: 5.361
Authors: Martin Zack; Tracy M Woodford; Anne M Tremblay; Lindsay Steinberg; Laurie A Zawertailo; Usoa E Busto Journal: Neuropsychopharmacology Date: 2010-10-06 Impact factor: 7.853
Authors: Winand H Dittrich; Thomas Johansen; Ashwini K Padhi; Ian E Smith; Samuel R Chamberlain; Naomi A Fineberg Journal: Psychopharmacology (Berl) Date: 2010-08-06 Impact factor: 4.530
Authors: Chelsea L Robertson; Kenji Ishibashi; Mark A Mandelkern; Amira K Brown; Dara G Ghahremani; Fred Sabb; Robert Bilder; Tyrone Cannon; Jacqueline Borg; Edythe D London Journal: J Neurosci Date: 2015-04-15 Impact factor: 6.167
Authors: Adam R Aron; Sarah Durston; Dawn M Eagle; Gordon D Logan; Cathy M Stinear; Veit Stuphorn Journal: J Neurosci Date: 2007-10-31 Impact factor: 6.167
Authors: Deanna M Barch; Todd S Braver; Cameron S Carter; Russell A Poldrack; Trevor W Robbins Journal: Schizophr Bull Date: 2008-11-14 Impact factor: 9.306
Authors: Ajna Hamidovic; Andrea Dlugos; Andrew Skol; Abraham A Palmer; Harriet de Wit Journal: Exp Clin Psychopharmacol Date: 2009-12 Impact factor: 3.157